BNP Paribas Financial Markets
RYTM icon

BNP Paribas Financial Markets’s Rhythm Pharmaceuticals RYTM Stock Holding History

BNP Paribas Financial Markets’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Sell
197,374
-50,502
-20% -$4.57M 0.01% 1196
2026
Q1 		$21.6M Buy
247,876
+83,313
+51% +$8.1M 0.01% 1103
2025
Q4 		$17.6M Sell
164,563
-59,118
-26% -$6.27M 0.01% 1261
2025
Q3 		$22.6M Buy
223,681
+121,442
+119% +$11.3M 0.01% 1048
2025
Q2 		$6.46M Buy
102,239
+16,173
+19% +$990K ﹤0.01% 1706
2025
Q1 		$4.56M Buy
86,066
+817
+1% +$45.3K ﹤0.01% 1870
2024
Q4 		$4.77M Buy
85,249
+70,824
+491% +$3.91M ﹤0.01% 1806
2024
Q3 		$756K Buy
14,425
+10,882
+307% +$521K ﹤0.01% 2651
2024
Q2 		$145K Sell
3,543
-52,466
-94% -$2.09M ﹤0.01% 3198
2024
Q1 		$2.43M Sell
56,009
-7,076
-11% -$310K ﹤0.01% 1939
2023
Q4 		$2.9M Buy
63,085
+7,842
+14% +$247K ﹤0.01% 1723
2023
Q3 		$1.27M Buy
55,243
+1,888
+4% +$42.3K ﹤0.01% 2173
2023
Q2 		$880K Sell
53,355
-33,687
-39% -$608K ﹤0.01% 2288
2023
Q1 		$1.55M Buy
87,042
+34,158
+65% +$858K ﹤0.01% 2004
2022
Q4 		$1.54M Sell
52,884
-28,049
-35% -$721K ﹤0.01% 1909
2022
Q3 		$1.98M Buy
80,933
+60,347
+293% +$1.12M ﹤0.01% 1966
2022
Q2 		$85.4K Buy
20,586
+8,822
+75% +$48.3K ﹤0.01% 3402
2022
Q1 		$136K Sell
11,764
-25,610
-69% -$225K ﹤0.01% 3267
2021
Q4 		$373K Buy
37,374
+26,466
+243% +$297K ﹤0.01% 3155
2021
Q3 		$142K Buy
10,908
+5,611
+106% +$85.7K ﹤0.01% 3158
2021
Q2 		$104K Sell
5,297
-9,437
-64% -$196K ﹤0.01% 3027
2021
Q1 		$313K Buy
14,734
+9,920
+206% +$288K ﹤0.01% 2825
2020
Q4 		$143K Sell
4,814
-3,100
-39% -$78.8K ﹤0.01% 3043
2020
Q3 		$171K Buy
7,914
+5,232
+195% +$120K ﹤0.01% 2827
2020
Q2 		$59.8K Sell
2,682
-10,078
-79% -$196K ﹤0.01% 2964
2020
Q1 		$194K Buy
12,760
+9,351
+274% +$167K ﹤0.01% 2874
2019
Q4 		$78.3K Sell
3,409
-17
-0.5% -$378 ﹤0.01% 3408
2019
Q3 		$74K Buy
3,426
+1,739
+103% +$37.3K ﹤0.01% 3278
2019
Q2 		$37.1K Sell
1,687
-1,479
-47% -$37.4K ﹤0.01% 3612
2019
Q1 		$86.8K Buy
3,166
+3,163
+105,433% +$90.9K ﹤0.01% 3209
2018
Q4 		$81 Sell
3
-592
-99% -$16.4K ﹤0.01% 4211
2018
Q3 		$17.4K Buy
595
+137
+30% +$4.33K ﹤0.01% 3468
2018
Q2 		$14.3K Sell
458
-918
-67% -$25.1K ﹤0.01% 3632
2018
Q1 		$27.4K Sell
1,376
-264
-16% -$7.01K ﹤0.01% 3837
2017
Q4 		$47.7K Buy
+1,640
New +$43.4K ﹤0.01% 3688

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BNP Paribas Financial Markets's RYTM Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Rhythm Pharmaceuticals (RYTM) stake by 20% in Q2 2026, selling an estimated $4.57M and leaving 197,374 shares worth $21.9M. The position accounts for 0.01% of the portfolio, ranked #1196.

BNP Paribas Financial Markets first reported a position in RYTM in Q4 2017 and has held it in 35 quarters since. The position peaked at $22.6M in Q3 2025. 279 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • BNP Paribas Financial Markets held 197,374 shares of Rhythm Pharmaceuticals worth $21.9M as of Q2 2026.
  • BNP Paribas Financial Markets sold 50,502 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.57M.
  • Rhythm Pharmaceuticals made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1196 holding.
  • BNP Paribas Financial Markets first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
  • BNP Paribas Financial Markets's Rhythm Pharmaceuticals position peaked at $22.6M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.